These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 18045076)
1. Yeast genomics and drug target identification. Bharucha N; Kumar A Comb Chem High Throughput Screen; 2007 Sep; 10(8):618-34. PubMed ID: 18045076 [TBL] [Abstract][Full Text] [Related]
2. Yeast on drugs: Saccharomyces cerevisiae as a tool for anticancer drug research. Menacho-Márquez M; Murguía JR Clin Transl Oncol; 2007 Apr; 9(4):221-8. PubMed ID: 17462974 [TBL] [Abstract][Full Text] [Related]
3. [Decade of genomics--methods for genome investigation in yeast Saccharomyces cerevisiae]. Skoneczna A Postepy Biochem; 2006; 52(4):435-47. PubMed ID: 17536513 [TBL] [Abstract][Full Text] [Related]
5. Yeast-based functional genomics and proteomics technologies: the first 15 years and beyond. Suter B; Auerbach D; Stagljar I Biotechniques; 2006 May; 40(5):625-44. PubMed ID: 16708762 [TBL] [Abstract][Full Text] [Related]
6. Yeast genomics and proteomics in drug discovery and target validation. Parsons AB; Geyer R; Hughes TR; Boone C Prog Cell Cycle Res; 2003; 5():159-66. PubMed ID: 14593709 [TBL] [Abstract][Full Text] [Related]
7. Towards high-throughput characterization of small molecule mechanisms of action. Luesch H Mol Biosyst; 2006 Dec; 2(12):609-20. PubMed ID: 17216042 [TBL] [Abstract][Full Text] [Related]
8. Off-target effects of psychoactive drugs revealed by genome-wide assays in yeast. Ericson E; Gebbia M; Heisler LE; Wildenhain J; Tyers M; Giaever G; Nislow C PLoS Genet; 2008 Aug; 4(8):e1000151. PubMed ID: 18688276 [TBL] [Abstract][Full Text] [Related]
9. A survey of yeast genomic assays for drug and target discovery. Smith AM; Ammar R; Nislow C; Giaever G Pharmacol Ther; 2010 Aug; 127(2):156-64. PubMed ID: 20546776 [TBL] [Abstract][Full Text] [Related]
10. Yeast as a model eukaryote in toxinology: a functional genomics approach to studying the molecular basis of action of pharmacologically active molecules. Mattiazzi M; Petrovič U; Križaj I Toxicon; 2012 Sep; 60(4):558-71. PubMed ID: 22465496 [TBL] [Abstract][Full Text] [Related]
11. Applications of yeast in drug discovery. Ma D Prog Drug Res; 2001; 57():117-62. PubMed ID: 11728000 [TBL] [Abstract][Full Text] [Related]
12. Target validation and drug discovery using genomic and protein-protein interaction technologies. Pillutla RC; Fisher PB; Blume AJ; Goldstein NI Expert Opin Ther Targets; 2002 Aug; 6(4):517-31. PubMed ID: 12223066 [TBL] [Abstract][Full Text] [Related]
13. Functional analysis of the yeast genome. Ross-Macdonald P Funct Integr Genomics; 2000 Sep; 1(2):99-113. PubMed ID: 11793226 [TBL] [Abstract][Full Text] [Related]
14. Chemical genetic and chemogenomic analysis in yeast. Coorey NV; Sampson LD; Barber JM; Bellows DS Methods Mol Biol; 2014; 1205():169-86. PubMed ID: 25213245 [TBL] [Abstract][Full Text] [Related]
15. [Drug discovery based on microarray]. Kuhara S; Tashiro K; Muta S Nihon Yakurigaku Zasshi; 2002 Nov; 120(1):47P-50P. PubMed ID: 12491777 [TBL] [Abstract][Full Text] [Related]
16. Yeast and drug discovery. Hughes TR Funct Integr Genomics; 2002 Sep; 2(4-5):199-211. PubMed ID: 12192593 [TBL] [Abstract][Full Text] [Related]
18. Progress in the genomics and genome-wide study of sake yeast. Akao T Biosci Biotechnol Biochem; 2019 Aug; 83(8):1463-1472. PubMed ID: 30835624 [TBL] [Abstract][Full Text] [Related]
19. Microarray karyotyping of commercial wine yeast strains reveals shared, as well as unique, genomic signatures. Dunn B; Levine RP; Sherlock G BMC Genomics; 2005 Apr; 6():53. PubMed ID: 15833139 [TBL] [Abstract][Full Text] [Related]
20. Yeast two-hybrid systems and protein interaction mapping projects for yeast and worm. Walhout AJ; Boulton SJ; Vidal M Yeast; 2000 Jun; 17(2):88-94. PubMed ID: 10900455 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]